VAERS reports by lot

GSK DTaP/Tdap lot ZN937: VAERS reports

26 VAERS reports list lot ZN937 as a GSK DTaP/Tdap vaccine, received between 2017-04-11 and 2019-01-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
23%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1819%
Injection-site / Local reaction1718%
Musculoskeletal1415%
Cardiac / Cardiovascular1112%
Neurological910%
Allergic / Anaphylactic89%
Gastrointestinal78%
Dermatological (non-injection-site)44%
Psychiatric / Neuropsychiatric33%
Autoimmune / Immune-mediated11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Texas2
Ohio2
Pennsylvania1
Florida1
Michigan1
Missouri1
Colorado1
Tennessee1
New Hampshire1
Illinois1
Louisiana1

Reports by month received

2017-042
2017-055
2017-065
2017-072
2017-081
2017-094
2017-101
2017-122
2018-012
2018-041
2019-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.